SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA: total counts of yeasts and molds are out of specification
Brand(s)
Last updated
Summary
Product
SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Jamp Senna | SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA | NPN 80009595 | Tablet | Sennoside A&B 8.6 mg | 2A02B3015 |
Issue
The combined total counts of yeasts and molds are out of specification in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Jamp Pharma Corporation
1310 rue Nobel,
Boucherville, Quebec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76913
Get notified
Receive emails about new and updated recall and safety alerts.